New phthalimide-based derivatives as EGFR-TK inhibitors: Synthesis, biological evaluation, and molecular modeling study
NI Mansour, SM El-Sayed, NS El-Gohary… - Bioorganic …, 2022 - Elsevier
A novel series of phthalimide derivatives was synthesized and evaluated for in vitro
antitumor activity against six human cancer cell lines; HepG-2, HCT-116, MCF-7, Hep2, PC3 …
antitumor activity against six human cancer cell lines; HepG-2, HCT-116, MCF-7, Hep2, PC3 …
New phthalimide-based derivatives as EGFR-TK inhibitors: Synthesis, biological evaluation, and molecular modeling study
NI Mansour, SM El-Sayed… - Bioorganic …, 2022 - pubmed.ncbi.nlm.nih.gov
A novel series of phthalimide derivatives was synthesized and evaluated for in vitro
antitumor activity against six human cancer cell lines; HepG-2, HCT-116, MCF-7, Hep2, PC3 …
antitumor activity against six human cancer cell lines; HepG-2, HCT-116, MCF-7, Hep2, PC3 …
New phthalimide-based derivatives as EGFR-TK inhibitors: Synthesis, biological evaluation, and molecular modeling study.
NI Mansour, SM El-Sayed, NS El-Gohary… - Bioorganic …, 2022 - europepmc.org
A novel series of phthalimide derivatives was synthesized and evaluated for in vitro
antitumor activity against six human cancer cell lines; HepG-2, HCT-116, MCF-7, Hep2, PC3 …
antitumor activity against six human cancer cell lines; HepG-2, HCT-116, MCF-7, Hep2, PC3 …